Structuring AI Innovation for a Global MedTech Enterprise
Designing the decision layer for their largest revenue-contributing division
AI innovation
regulated industries
product-Service design
ROLE
Strategic Designer
INDUSTRY
Medical technology
Timeline
Jan'25
(3 week sprint)

A large medtech organisation was pushing hard on AI as a strategic priority. Ideas were forming across the customer services team, but arriving half-formed, and always
at the same bottleneck.
Investments were being made before the right questions had been asked. Customer value wasn't being realised, and leadership had no real visibility into the innovation pulse of the team. As a result, initiatives were duplicated, with no institutional learning.
The right conversations were already happening just informally, inconsistently, too late. The intelligence existed inside the organisation, but had no structure.
And the entire weight of making AI innovation work was concentrated on one person.
In a regulated environment operating under the EU AI Act, early decisions about data, compliance, and ownership have consequences that are hard to undo
The Act mandates continuous risk management and documented data assumptions throughout the AI lifecycle, not at the end of it.

Solution overview - INTERNAL SERVICE-SYSTEM



A guided entry flow surfaces assumptions and uncertainties early. A shared living canvas makes thinking visible to the right people simultaneously. An intelligent routing system directs conversations to legal, data, and technical experts in a prioritised sequence, constraints discovered before commitment,
ENABLING LEADERSHIP VISIBILITY


Tracking success

Time to Evaluation
The time an idea spends in early sensemaking before reaching a clear outcome.
AI Registry Consultation
Whether contributors actively check existing initiatives before submitting or progressing an idea.
Anuja Kulkarni
© 2026. All Rights Reserved.